Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation.

Kaffenberger BH, Wong HK, Jarjour W, Andritsos LA.

J Am Acad Dermatol. 2013 Mar;68(3):489-92. doi: 10.1016/j.jaad.2012.08.021. Epub 2012 Sep 12. Review.

PMID:
22981608
[PubMed - indexed for MEDLINE]
2.

[Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].

Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):389-92. Chinese.

PMID:
15355688
[PubMed - indexed for MEDLINE]
3.

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.

Blau IW, Basara N, Bischoff M, Günzelmann S, Römer E, Kirsten D, Schmetzer B, Kiehl MG, Fauser AA.

Bone Marrow Transplant. 2000 Jan;25(1):41-5.

PMID:
10654013
[PubMed - indexed for MEDLINE]
Free Article
4.

Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.

Hommes DW, Duijvestein M, Zelinkova Z, Stokkers PC, Ley MH, Stoker J, Voermans C, van Oers MH, Kersten MJ.

J Crohns Colitis. 2011 Dec;5(6):543-9. doi: 10.1016/j.crohns.2011.05.004. Epub 2011 Jun 12.

PMID:
22115372
[PubMed - indexed for MEDLINE]
5.

Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.

Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G, Espigado I, Iriondo A, Jost L, Koza V, Lenhoff S, Lisukov I, Locatelli F, Marmont A, Philippe P, Pilatrino C, Quartier P, Stary J, Veys P, Vormoor J, Wahlin A, Zintl F, Bocelli-Tyndall C, Tyndall A, Gratwohl A; Autoimmune Disease Working Party of the EBMT.

Br J Haematol. 2004 Jun;125(6):749-55.

PMID:
15180864
[PubMed - indexed for MEDLINE]
6.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K; Lymphoma Working Committee of the International Bone Marrow Transplant Registry.

Blood. 2004 Dec 1;104(12):3797-803. Epub 2004 Jul 27.

PMID:
15280203
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).

Fouillard L, Labopin M, Gorin NC, Polge E, Prentice HG, Meloni G, Reiffers J, Pigneux A, Willemze R, Schattenberg A, Sica S, Lagrange M, Fenneteau O, Perot C, Frassoni F; Acute Leukemia Working Party of the EBMT.

Blood. 2002 Nov 1;100(9):3135-40.

PMID:
12384410
[PubMed - indexed for MEDLINE]
Free Article
9.

[Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].

Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.

Ai Zheng. 2004 Apr;23(4):426-9. Chinese.

PMID:
15087032
[PubMed - indexed for MEDLINE]
10.

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.

Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Körholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nürnberger W, Heyll A, Ladenstein R, Gadner H, Jürgens H, Go el U.

Ann Oncol. 2000 Nov;11(11):1451-62. Review.

PMID:
11142486
[PubMed - indexed for MEDLINE]
Free Article
11.

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.

Tichelli A, Bucher C, Rovó A, Stussi G, Stern M, Paulussen M, Halter J, Meyer-Monard S, Heim D, Tsakiris DA, Biedermann B, Passweg JR, Gratwohl A.

Blood. 2007 Nov 1;110(9):3463-71. Epub 2007 Jul 30.

PMID:
17664354
[PubMed - indexed for MEDLINE]
Free Article
12.

Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma.

Laudi N, Arora M, Burns L, McGlave P, Miller J, Bohac G, Rogers T, Barker J, Coad J, Weisdorf D.

Am J Hematol. 2006 Jul;81(7):519-24.

PMID:
16755570
[PubMed - indexed for MEDLINE]
13.

A long-term follow-up analysis in adult acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Annaloro C, Zilioli VR, Fracchiolla NS, Vener C, Soligo D, Della Volpe A, Deliliers GL.

Tumori. 2005 Sep-Oct;91(5):388-93.

PMID:
16459634
[PubMed - indexed for MEDLINE]
14.

Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.

Hsieh YY, Hong YC, Hsiao LT, Yu YB, Liu JH, Gau JP, Lin HN, Hsu YN, Chiou TJ, Chen PM, Tzeng CH, Liu CY.

Eur J Haematol. 2011 Mar;86(3):237-45. doi: 10.1111/j.1600-0609.2010.01560.x. Epub 2011 Jan 11.

PMID:
21155895
[PubMed - indexed for MEDLINE]
15.

High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML.

O'Meara A, Pabst T, Heim D, Gerull S, Bucher C, Halter J, Arber C, Rovò A, Tichelli A, Gratwohl A, Stern M.

Bone Marrow Transplant. 2011 May;46(5):636-40. doi: 10.1038/bmt.2010.181. Epub 2010 Aug 9.

PMID:
20697364
[PubMed - indexed for MEDLINE]
16.

A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97.

Vesole DH, Zhang L, Flomenberg N, Greipp PR, Lazarus HM, Huff CA; ECOG Myeloma and BMT Committees.

Biol Blood Marrow Transplant. 2009 Jan;15(1):83-91. doi: 10.1016/j.bbmt.2008.10.030. Erratum in: Biol Blood Marrow Transplant. 2009 Oct;15(10):1346. Huff, Carol A [added].

PMID:
19135946
[PubMed - indexed for MEDLINE]
17.

Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.

Auberger J, Clausen J, Willenbacher W, Erdel M, Gunsilius E, Petzer A, Gastl G, Nachbaur D.

Int J Hematol. 2008 May;87(4):382-6. doi: 10.1007/s12185-008-0084-5.

PMID:
18418698
[PubMed - indexed for MEDLINE]
18.

Secondary failure of platelet recovery after hematopoietic stem cell transplantation.

Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, Nash RA.

Biol Blood Marrow Transplant. 2001;7(3):154-62.

PMID:
11302549
[PubMed - indexed for MEDLINE]
19.

Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Costa LJ, Kumar S, Dispenzieri A, Hayman SE, Buadi FK, Dingli D, Litzow MR, Gertz MA, Lacy MQ.

Leuk Lymphoma. 2009 May;50(5):781-7. doi: 10.1080/10428190902803644.

PMID:
19330657
[PubMed - indexed for MEDLINE]
20.

The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.

Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A, Koza V, Kienast J, Niederwieser D, de Witte T, Ruutu T; complications subcommittee of the Chronic Leukemia Working Party.

Bone Marrow Transplant. 2008 Dec;42(11):739-42. doi: 10.1038/bmt.2008.254. Epub 2008 Aug 25.

PMID:
18724394
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk